Literature DB >> 32009620

Single dose aspirin affects fecal immunohistochemical test sensitivity in detecting advanced colorectal neoplasms: Truth or expectation?

Yonca Yılmaz Ürün1, Selim Aydemir1.   

Abstract

Entities:  

Year:  2020        PMID： 32009620      PMCID： PMC7075682          DOI： 10.5152/tjg.2020.090120

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN： 1300-4948            Impact factor:   1.852


× No keyword cloud information.
  14 in total

1.  Gender differences in gut transit shown with a newly developed radiological procedure.

Authors:  R Sadik; H Abrahamsson; P O Stotzer
Journal:  Scand J Gastroenterol       Date:  2003-01       Impact factor: 2.423

2.  Performance Characteristics of Fecal Immunochemical Tests for Colorectal Cancer and Advanced Adenomatous Polyps: A Systematic Review and Meta-analysis.

Authors:  Thomas F Imperiale; Rachel N Gruber; Timothy E Stump; Thomas W Emmett; Patrick O Monahan
Journal:  Ann Intern Med       Date:  2019-02-26       Impact factor: 25.391

3.  Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants.

Authors:  Zohar Levi; Paul Rozen; Rachel Hazazi; Alex Vilkin; Amal Waked; Eran Maoz; Shlomo Birkenfeld; Nicky Lieberman; Shmuel Klang; Yaron Niv
Journal:  Am J Gastroenterol       Date:  2009-03-17       Impact factor: 10.864

Review 4.  Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update.

Authors:  Paul Hewitson; Paul Glasziou; Eila Watson; Bernie Towler; Les Irwig
Journal:  Am J Gastroenterol       Date:  2008-05-13       Impact factor: 10.864

5.  Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program.

Authors:  Manon van der Vlugt; Esmée J Grobbee; Patrick M Bossuyt; Amanda C R K Bos; Ernst J Kuipers; Iris Lansdorp-Vogelaar; Manon C W Spaander; Evelien Dekker
Journal:  Clin Gastroenterol Hepatol       Date:  2018-02-07       Impact factor: 11.382

6.  Low-dose aspirin use and performance of immunochemical fecal occult blood tests.

Authors:  Hermann Brenner; Sha Tao; Ulrike Haug
Journal:  JAMA       Date:  2010-12-08       Impact factor: 56.272

Review 7.  Sex-biased eicosanoid biology: Impact for sex differences in inflammation and consequences for pharmacotherapy.

Authors:  Simona Pace; Lidia Sautebin; Oliver Werz
Journal:  Biochem Pharmacol       Date:  2017-06-22       Impact factor: 5.858

8.  European Code against Cancer, 4th Edition: Cancer screening.

Authors:  Paola Armaroli; Patricia Villain; Eero Suonio; Maribel Almonte; Ahti Anttila; Wendy S Atkin; Peter B Dean; Harry J de Koning; Lena Dillner; Rolando Herrero; Ernst J Kuipers; Iris Lansdorp-Vogelaar; Silvia Minozzi; Eugenio Paci; Jaroslaw Regula; Sven Törnberg; Nereo Segnan
Journal:  Cancer Epidemiol       Date:  2015-12       Impact factor: 2.984

9.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

10.  Colorectal cancer after negative colonoscopy in fecal immunochemical test-positive participants from a colorectal cancer screening program.

Authors:  Liseth Rivero-Sánchez; Jaume Grau; Josep María Augé; Lorena Moreno; Angels Pozo; Anna Serradesanferm; Mireia Díaz; Sabela Carballal; Ariadna Sánchez; Leticia Moreira; Francesc Balaguer; Maria Pellisé; Antoni Castells
Journal:  Endosc Int Open       Date:  2018-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.